Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Neuropharmacology 168 , 107757 (2020)
)
Postbiotics: An overview of concepts, inactivation technologies, health effects, and driver trends
The biphasic response suggests possible mechanisms: lower doses (nanogram range) might work through growth factor upregulation and signaling cascade amplification, while higher doses (microgram range) might involve direct receptor activation or substrate provision for cellular repair
& Al-Domi, H
After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology Jean-Michel Dogns Post The benefits of GLP-1 drugs beyond obesity Excellent review on the Glucagon-like peptide1based medicines #diabetes and weight lossindependent actions
